Ahead of the Bell: Zogenix updates on pain drug - BusinessWeek

[INCIID News Feed]

Proactive Investors USA & Canada
<img alt="" height="1" width="1" />
Ahead of the Bell: Zogenix updates on pain drug
BusinessWeek
Shares of Zogenix rose 4 percent in premarket trading Wednesday after it said its chronic pain treatment did well in a late-stage study. The drug developer expects to submit an application for approval for Zohydro to the Food and Drug Administration by ...
Zogenix Phase 3 Zohydro study meets primary endpointPharmaceutical Business Review
Zogenix Pain Drug Zohydro Meets Primary Endpoint In Phase 3 Study - UpdateRTT News
Zogenix plots marketing app as pain drug clears PhIIIFierceBiotech
MarketWatch -SignOnSanDiego.com -Beacon Equity Research
all 26 news articles &raquo;


More...